Promising results with the daily oral small molecule lipoprotein(a) inhibitor, muvalaplin, in high-risk cardiovascular patients with elevated lipoprotein(a) levels
@article{ATM137644, author = {Alpo Vuorio and Petri T. Kovanen and Frederick Raal}, title = {Promising results with the daily oral small molecule lipoprotein(a) inhibitor, muvalaplin, in high-risk cardiovascular patients with elevated lipoprotein(a) levels}, journal = {Annals of Translational Medicine}, volume = {13}, number = {2}, year = {2025}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/137644} }